GMO - innovative biotechnology in 21st century medicine
Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS
Monografia opublikowana w zeszycie Biotechnologia 2(85)'2009
Genetically modified organisms are the key step for innovative medicines. The innovative drugs in the 21*' century will be in the majority of proteins, nucleic acids and their combinations. The critical issues in case of biopharmaceuticals are quality and reproducibility of production. These aspects are evident in biosimilars (generics) and protection of intellectual property rights.
0860-7796 ; oai:rcin.org.pl:72132 ; IChB B-80
Library of Institute of Bioorganic Chemistry PAS
Creative Commons Attribution BY-SA 4.0 license
Institute of Bioorganic Chemistry of the Polish Academy of Science
Institute of Bioorganic Chemistry of the Polish Academy of Science
Oct 2, 2020
Jun 3, 2019
1060
https://rcin.org.pl/publication/94539
Edition name | Date |
---|---|
GMO, czyli innowacyjne biotechnologie w medycynie XXI w. | Oct 2, 2020 |
Twardowska, Aleksandra Twardowski, Tomasz
Lubiatowska-Krysiak, Eliza Twardowski, Tomasz
Borkowska, Bożenna
Ziółkowski, Piotr Babula- Skowrońska, Danuta Kaczmarek, Małgorzata Cieśla, Agata Sadowski, Jan
Kaliszan, Roman Długokęcka, Justyna